Biofrontera (BFRI) Asset Writedowns and Impairment (2020 - 2025)
Biofrontera has reported Asset Writedowns and Impairment over the past 6 years, most recently at -$25000.0 for Q4 2025.
- For Q4 2025, Asset Writedowns and Impairment fell 149.02% year-over-year to -$25000.0; the TTM value through Dec 2025 reached -$69000.0, down 142.59%, while the annual FY2025 figure was -$69000.0, 142.59% down from the prior year.
- Asset Writedowns and Impairment for Q4 2025 was -$25000.0 at Biofrontera, down from $13000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $94000.0 in Q3 2023 and troughed at -$46000.0 in Q1 2025.
- A 5-year average of $17700.0 and a median of $12000.0 in 2024 define the central range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 4650.0% in 2022 and fell as far as 833.33% in 2022.
- Year by year, Asset Writedowns and Impairment stood at -$3000.0 in 2021, then plummeted by 66.67% to -$5000.0 in 2022, then plummeted by 620.0% to -$36000.0 in 2023, then soared by 241.67% to $51000.0 in 2024, then tumbled by 149.02% to -$25000.0 in 2025.
- Business Quant data shows Asset Writedowns and Impairment for BFRI at -$25000.0 in Q4 2025, $13000.0 in Q3 2025, and -$11000.0 in Q2 2025.